Neuronetics, Inc.
Neuronetics, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 19 | 13 | 28 | 28 | 11 | 20 | 18 | 21 | 43 | 48 | 60 | 36 | |||||
Restricted Cash And Cash Equivalents At Carrying V… | 6 | 6 | 6 | 7 | 7 | 1 | 1 | - | - | - | - | - | |||||
Restricted Cash Current | - | - | 1 | - | - | 1 | 1 | - | - | - | - | - | |||||
Accounts Receivable Net Current | 16 | 16 | 16 | 19 | 26 | 26 | 23 | 17 | 17 | 18 | 16 | 15 | |||||
Inventory Net | 6 | 5 | 4 | 4 | 5 | 4 | 4 | 5 | 6 | 7 | 8 | 10 | |||||
Net Investment In Lease Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||
Prepaid Expense Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | |||||
Prepaid Expense And Other Assets Current | 4 | 4 | 3 | 4 | 4 | 5 | 7 | 5 | 4 | 4 | 5 | 5 | |||||
Assets Current | 53 | 47 | 62 | 65 | 56 | 61 | 58 | 53 | 76 | 82 | 94 | 71 | |||||
Property Plant And Equipment Net | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 2 | 2 | 2 | 2 | 2 | |||||
Goodwill | 24 | 24 | 24 | 23 | 19 | 19 | 19 | - | - | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 17 | 18 | 18 | 19 | 19 | 19 | 20 | - | - | - | - | - | |||||
Operating Lease Right Of Use Asset | 24 | 23 | 24 | 24 | 24 | 27 | 27 | 2 | 2 | 3 | 3 | 3 | |||||
Net Investment In Lease Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Prepaid Expense Noncurrent | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 8 | 8 | 8 | |||||
Notes And Loans Receivable Net Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 4 | 4 | 4 | |||||
Other Assets Noncurrent | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 5 | 5 | 5 | 4 | 4 | |||||
Assets | 132 | 125 | 142 | 145 | 135 | 142 | 141 | 74 | 97 | 104 | 116 | 93 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 12 | 11 | 11 | 12 | 10 | 8 | 11 | 3 | 4 | 3 | 5 | 3 | |||||
Accrued Liabilities Current | 9 | 10 | 12 | 10 | 11 | 9 | 13 | 11 | 9 | 9 | 13 | 10 | |||||
Deferred Revenue Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Business Combination Contingent Consideration Liab… | 0 | 0 | 1 | 1 | 1 | 1 | 1 | - | - | - | - | - | |||||
Other Liabilities Current | 0 | 1 | 1 | 0 | 0 | 0 | 1 | - | - | - | - | - | |||||
Operating Lease Liability Current | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 1 | 1 | 1 | 1 | 1 | |||||
Long Term Debt Current | - | - | - | - | - | - | - | - | 14 | - | - | - | |||||
Liabilities Current | 28 | 28 | 31 | 29 | 28 | 25 | 31 | 17 | 29 | 14 | 20 | 15 | |||||
Long Term Debt Noncurrent | 62 | 61 | 66 | 66 | 56 | 55 | 55 | 46 | 46 | 59 | 59 | 37 | |||||
Other Liabilities Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Deferred Revenue Noncurrent | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 20 | 19 | 19 | 19 | 20 | 22 | 23 | 2 | 2 | 2 | 2 | 3 | |||||
Liabilities | 110 | 108 | 115 | 114 | 103 | 102 | 109 | 65 | 77 | 76 | 82 | 55 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 490 | 482 | 480 | 478 | 469 | 467 | 447 | 416 | 413 | 411 | 410 | 408 | |||||
Retained Earnings Accumulated Deficit | -473 | -470 | -459 | -452 | -443 | -432 | -420 | -407 | -394 | -384 | -376 | -371 | |||||
Stockholders Equity | 22 | 13 | 26 | 27 | 32 | 40 | 32 | 9 | 19 | 28 | 34 | 38 | |||||
Minority Interest | 4 | 4 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | - | |||||
Liabilities And Stockholders Equity | 132 | 125 | 142 | 145 | 135 | 142 | 141 | 74 | 97 | 104 | 116 | 93 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | - | - | - | 1 | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 200 | 200 | 200 | 250 | 200 | |||||
Common Stock Shares Issued | 76 | 70 | 69 | 68 | 66 | 66 | 56 | 30 | 30 | 30 | 29 | 29 | |||||
Shares Outstanding | 76 | 70 | 69 | 68 | 66 | 66 | 56 | 30 | 30 | 30 | 29 | 29 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -29.03% | -38.25% | -20.28% | - | - | - | - | - | - | - | - | - |
| 2025 | -13.11% | -21.56% | -0.22% | -26.73% | -40.37% | -31.35% | -48.08% | -50.52% | -25.78% | 10.20% | 35.10% | 5.31% |
| 2024 | -26.15% | -30.77% | -27.31% | 4.03% | 14.09% | 38.26% | 84.06% | 115.94% | 349.28% | -6.00% | 5.50% | -5.25% |
| 2023 | - | - | - | - | - | - | 45.00% | 107.14% | 139.29% | 15.53% | -15.29% | -47.09% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.88 | 1.67 | 2.02 | 2.24 | 2.02 | 2.44 | 1.86 | 3.16 | 2.58 | 5.65 | 4.73 | 4.63 | |||||
| Quick Ratio | 1.59 | 1.40 | 1.77 | 1.99 | 1.73 | 2.15 | 1.62 | 2.70 | 2.28 | 5.00 | 4.20 | 3.84 | |||||
| Working Capital | 24.92M | 18.89M | 31.03M | 35.95M | 28.34M | 35.83M | 26.86M | 36.56M | 46.25M | 67.37M | 73.98M | 55.68M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 5.08 | 8.17 | 4.39 | 4.17 | 3.27 | 2.59 | 3.43 | 6.90 | 3.99 | 2.75 | 2.39 | 1.45 | |||||
| Interest Coverage TTM | -3.47 | -4.57 | -5.16 | -4.82 | -5.19 | -5.24 | -4.74 | -3.73 | -4.20 | -4.59 | -5.63 | -7.06 | |||||
| Debt Ratio | 0.84 | 0.86 | 0.81 | 0.78 | 0.77 | 0.72 | 0.77 | 0.87 | 0.80 | 0.73 | 0.70 | 0.59 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.17 | 1.13 | 1.06 | 1.18 | 0.96 | 0.73 | 0.58 | 0.87 | 0.73 | 0.71 | 0.61 | 0.65 | |||||
| Days Sales Outstanding TTM | 49.50 | 50.55 | 48.73 | 49.91 | 71.06 | 89.16 | 95.37 | 79.94 | 76.70 | 67.18 | 75.13 | 71.14 | |||||
| Receivables Turnover TTM | 7.37 | 7.22 | 7.49 | 7.31 | 5.14 | 4.09 | 3.83 | 4.57 | 4.76 | 5.43 | 4.86 | 5.13 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.42 | -0.54 | -0.59 | -0.66 | -0.74 | -0.79 | -1.38 | -1.20 | -1.08 | -0.93 | -1.05 | -1.15 | |||||
| Free Cash Flow Per Share TTM | -0.26 | -0.20 | -0.32 | -0.20 | -0.28 | -0.61 | -1.02 | -0.74 | -0.91 | -1.06 | -1.20 | -1.36 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 49.12% | 47.96% | 48.48% | 50.43% | 56.15% | 63.51% | 72.32% | 75.70% | 73.27% | 72.92% | 72.47% | 71.85% | |||||
| Operating Profit Margin TTM | -14.74% | -19.40% | -21.08% | -29.15% | -34.44% | -43.29% | -46.15% | -37.85% | -39.78% | -37.56% | -42.82% | -48.90% | |||||
| Net Profit Margin TTM | -19.72% | -24.56% | -26.24% | -34.27% | -43.92% | -54.23% | -58.36% | -50.09% | -45.06% | -37.61% | -42.31% | -47.81% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 39.59% | 69.52% | 99.17% | 78.62% | 54.17% | 22.16% | 4.96% | 5.03% | 6.22% | 10.01% | 9.42% | 11.61% | |||||
| Net Income Growth (1Y) | -37.33% | -23.23% | -10.46% | 22.18% | 50.27% | 76.13% | 44.78% | 10.03% | 3.68% | -25.24% | -18.76% | -9.32% | |||||
| EPS Growth (1Y) | -43.28% | -32.19% | -56.92% | -45.06% | -31.76% | -15.55% | 30.75% | 4.98% | -1.36% | -28.89% | -23.74% | -15.32% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -3.11 | -2.71 | -2.33 | -4.13 | -4.73 | -4.66 | -1.17 | -0.63 | -1.67 | -5.09 | -2.75 | -1.18 | |||||
| P/B TTM | 4.39 | 7.61 | 3.47 | 6.72 | 7.33 | 5.72 | 1.61 | 2.45 | 2.79 | 5.07 | 2.43 | 1.03 | |||||
| P/S TTM | 0.61 | 0.67 | 0.61 | 1.41 | 2.08 | 2.53 | 0.68 | 0.32 | 0.75 | 1.92 | 1.16 | 0.56 | |||||
| Market Cap | 95.07M | 100.90M | 91.01M | 183.75M | 230.97M | 226.19M | 51.09M | 23.00M | 54.09M | 140.29M | 83.11M | 38.98M | |||||
| Enterprise Value | 131.64M | 143.24M | 122.69M | 214.95M | 269.04M | 260.31M | 86.78M | 48.14M | 71.21M | 152.00M | 82.71M | 39.99M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -18.84M | -13.58M | -21.18M | -13.34M | -18.24M | -37.29M | -32.46M | -22.52M | -27.40M | -31.35M | -34.41M | -39.26M | |||||
| Net Debt | 36.57M | 42.33M | 31.67M | 31.20M | 38.07M | 34.12M | 35.69M | 25.14M | 17.12M | 11.71M | -394.00K | 1.00M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Neuronetics, Inc. (STIM) — SEC Financial Statements & Analysis
Neuronetics, Inc. (STIM) is a surgical & medical instruments & apparatus company, incorporated in DE. Neuronetics, Inc. trades on Nasdaq as: STIM. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Neuronetics, Inc. reported a 39.59% year-over-year revenue growth, a Gross Profit Margin of 49.12% (TTM), a Debt-to-Equity ratio of 5.08x, a Price-to-Sales (P/S) ratio of 0.61x (TTM), a Price-to-Book (P/B) ratio of 4.39x (TTM), at a market cap of $95.07M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 39.59%
- Gross Profit Margin TTM
- 49.12%
- Debt To Equity
- 5.08x
- P/S TTM
- 0.61x
- P/B TTM
- 4.39x
- Market Cap
- $95.07M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Neuronetics, Inc. in?
Neuronetics, Inc. (STIM) operates in the Surgical & Medical Instruments & Apparatus industry.
What is STIM's market cap?
Neuronetics, Inc. (STIM) has a market capitalization of $95.07M as of 2026-06-30.
What exchange does STIM trade on?
Neuronetics, Inc. (STIM) trades on the Nasdaq.
Where is Neuronetics, Inc. incorporated?
Neuronetics, Inc. is incorporated in DE.